Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067261458> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2067261458 endingPage "231" @default.
- W2067261458 startingPage "228" @default.
- W2067261458 abstract "Corticosteroids are used as a daily oral therapy or in a pulse form with or without various adjuvant drugs for the treatment of pemphigus. Our long-term experience with the use of dexamethasone-cyclophosphamide pulse therapy as a first-line treatment modality for pemphigus is presented.A retrospective analysis of records of pemphigus patients treated by dexamethasone-cyclophosphamide therapy was carried out. The treatment regimen consisted of the monthly administration of intravenous dexamethasone (136 mg) for 3 consecutive days with addition of intravenous cyclophosphamide (500 mg) on the second day. Oral cyclophosphamide (50 mg) daily and oral corticosteroids (low tapering doses) were given in the intervals between the pulses, till partial remission was achieved. Pulse therapy was then continued for another 6 months followed by daily oral cyclophosphamide (50 mg) for 1 year, which produced a complete remission.A total of 36 patients, 32 with pemphigus vulgaris and 4 with pemphigus foliaceus, were treated with this regimen. Two to 8 pulses were required to achieve a partial remission, while the total number of pulses given for complete remission ranged from 8 to 32. The duration of pulse therapy correlated with both the disease severity and the time to achieve remission. All patients are now in complete remission with a follow-up of 0.5-12 years. Four patterns of remission were observed, related to the severity of disease. The response to pulse therapy was faster in the milder form of disease. The severe form of disease required more pulses as well as higher doses of intervening oral corticosteroids.Dexamethasone-cyclophosphamide pulse therapy is an effective form of treatment in pemphigus and results in long-lasting remissions." @default.
- W2067261458 created "2016-06-24" @default.
- W2067261458 creator A5060966877 @default.
- W2067261458 creator A5061087597 @default.
- W2067261458 creator A5075500019 @default.
- W2067261458 date "2002-01-01" @default.
- W2067261458 modified "2023-10-18" @default.
- W2067261458 title "Long-Term Efficacy of Dexamethasone-Cyclophosphamide Pulse Therapy in Pemphigus" @default.
- W2067261458 cites W4244788032 @default.
- W2067261458 cites W4252099102 @default.
- W2067261458 cites W4254636038 @default.
- W2067261458 doi "https://doi.org/10.1159/000057886" @default.
- W2067261458 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12037452" @default.
- W2067261458 hasPublicationYear "2002" @default.
- W2067261458 type Work @default.
- W2067261458 sameAs 2067261458 @default.
- W2067261458 citedByCount "39" @default.
- W2067261458 countsByYear W20672614582013 @default.
- W2067261458 countsByYear W20672614582014 @default.
- W2067261458 countsByYear W20672614582015 @default.
- W2067261458 countsByYear W20672614582016 @default.
- W2067261458 countsByYear W20672614582017 @default.
- W2067261458 countsByYear W20672614582018 @default.
- W2067261458 countsByYear W20672614582019 @default.
- W2067261458 countsByYear W20672614582021 @default.
- W2067261458 crossrefType "journal-article" @default.
- W2067261458 hasAuthorship W2067261458A5060966877 @default.
- W2067261458 hasAuthorship W2067261458A5061087597 @default.
- W2067261458 hasAuthorship W2067261458A5075500019 @default.
- W2067261458 hasConcept C126322002 @default.
- W2067261458 hasConcept C141071460 @default.
- W2067261458 hasConcept C16005928 @default.
- W2067261458 hasConcept C2776694085 @default.
- W2067261458 hasConcept C2776755627 @default.
- W2067261458 hasConcept C2780401358 @default.
- W2067261458 hasConcept C2781313415 @default.
- W2067261458 hasConcept C2781327288 @default.
- W2067261458 hasConcept C2781413609 @default.
- W2067261458 hasConcept C71924100 @default.
- W2067261458 hasConcept C90924648 @default.
- W2067261458 hasConceptScore W2067261458C126322002 @default.
- W2067261458 hasConceptScore W2067261458C141071460 @default.
- W2067261458 hasConceptScore W2067261458C16005928 @default.
- W2067261458 hasConceptScore W2067261458C2776694085 @default.
- W2067261458 hasConceptScore W2067261458C2776755627 @default.
- W2067261458 hasConceptScore W2067261458C2780401358 @default.
- W2067261458 hasConceptScore W2067261458C2781313415 @default.
- W2067261458 hasConceptScore W2067261458C2781327288 @default.
- W2067261458 hasConceptScore W2067261458C2781413609 @default.
- W2067261458 hasConceptScore W2067261458C71924100 @default.
- W2067261458 hasConceptScore W2067261458C90924648 @default.
- W2067261458 hasIssue "3" @default.
- W2067261458 hasLocation W20672614581 @default.
- W2067261458 hasLocation W20672614582 @default.
- W2067261458 hasOpenAccess W2067261458 @default.
- W2067261458 hasPrimaryLocation W20672614581 @default.
- W2067261458 hasRelatedWork W180716608 @default.
- W2067261458 hasRelatedWork W2024381664 @default.
- W2067261458 hasRelatedWork W2052457199 @default.
- W2067261458 hasRelatedWork W2065988771 @default.
- W2067261458 hasRelatedWork W2093554044 @default.
- W2067261458 hasRelatedWork W2110334588 @default.
- W2067261458 hasRelatedWork W2148488868 @default.
- W2067261458 hasRelatedWork W2528259868 @default.
- W2067261458 hasRelatedWork W3201788741 @default.
- W2067261458 hasRelatedWork W4220695894 @default.
- W2067261458 hasVolume "204" @default.
- W2067261458 isParatext "false" @default.
- W2067261458 isRetracted "false" @default.
- W2067261458 magId "2067261458" @default.
- W2067261458 workType "article" @default.